Jacobs Levy Equity Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-756,675
| Closed | -$2.3M | – | 1063 |
|
|
2021
Q4 | $2.3M | Buy |
756,675
+313,594
| +71% | +$953K | 0.02% | 592 |
|
|
2021
Q3 | $3.11M | Buy |
443,081
+262,137
| +145% | +$1.84M | 0.02% | 531 |
|
|
2021
Q2 | $1.66M | Buy |
180,944
+6,251
| +4% | +$57.4K | 0.01% | 636 |
|
|
2021
Q1 | $1.7M | Buy |
174,693
+71,165
| +69% | +$692K | 0.01% | 636 |
|
|
2020
Q4 | $1.06M | Sell |
103,528
-1,015
| -1% | -$10.4K | 0.01% | 706 |
|
|
2020
Q3 | $1.06M | Sell |
104,543
-4,146
| -4% | -$41.8K | 0.01% | 652 |
|
|
2020
Q2 | $1.13M | Buy |
108,689
+25,244
| +30% | +$263K | 0.01% | 643 |
|
|
2020
Q1 | $704K | Sell |
83,445
-42,730
| -34% | -$361K | 0.01% | 697 |
|
|
2019
Q4 | $1.1M | Buy |
126,175
+21,355
| +20% | +$187K | 0.01% | 674 |
|
|
2019
Q3 | $1.13M | Buy |
104,820
+66,460
| +173% | +$715K | 0.01% | 601 |
|
|
2019
Q2 | $488K | Sell |
38,360
-5,220
| -12% | -$66.4K | 0.01% | 743 |
|
|
2019
Q1 | $1.69M | Buy |
43,580
+26,040
| +148% | +$1.01M | 0.02% | 547 |
|
|
2018
Q4 | $357K | Buy |
17,540
+12,330
| +237% | +$251K | 0.01% | 785 |
|
|
2018
Q3 | $239K | Buy |
+5,210
| New | +$239K | ﹤0.01% | 903 |
|
|
2018
Q1 | – | Sell |
-7,297
| Closed | -$721K | – | 1041 |
|
|
2017
Q4 | $721K | Buy |
+7,297
| New | +$721K | 0.01% | 682 |
|